Clinical Trial Update: Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating camrelizumab in combination with apatinib for advanced sarcomatoid carcinoma or carcinosarcoma; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcoma
• Sarcomatoid Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Fudan University | Conditions: PD-1 Immunotherapy, VEGFR-TKI | Phase 2 | Status: UNKNOWN